Takeda's Strategy Is Focused on Core Business, CEO Says

The transcript discusses the company's financial health, focusing on profitability and past acquisitions. It highlights the balance between debt management and R&D partnerships, emphasizing the importance of maintaining investment grade. The challenges of developing innovative medicines in a competitive environment are addressed, with a focus on specific therapy areas. Market pressures, including pricing and globalization, are discussed, along with the impact of US tax laws on expansion plans.

How has the company's profitability changed over time?

What is the current focus of the business regarding acquisitions?

How does the company plan to maintain its financial position while pursuing partnerships?

What challenges does the pharmaceutical industry face in 2018?

What are the key areas of focus for the company's research and development?

What is the company's strategy for dealing with pricing pressures in the healthcare system?

What impact does the new tax law have on the company's operations in the US?